BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3906 related articles for article (PubMed ID: 7168010)

  • 1. Circulating immune complexes in human malignant melanoma.
    D'Amelio R; Cooke B; Hobbs JR
    Tumori; 1982 Dec; 68(6):469-72. PubMed ID: 7168010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
    Wong JH; Gupta RK; Morton DL
    Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating immune complexes in the serum of tumor patients].
    Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
    Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in malignant melanoma.
    Gupta RK
    Dis Markers; 1988 Jun; 6(2):81-95. PubMed ID: 3042263
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
    Morgan AC; McIntyre RF
    Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between circulating immune complexes and urinary antigens in human malignancy.
    Huth JF; Gupta RK; Morton DL
    Cancer; 1982 Mar; 49(6):1150-7. PubMed ID: 7037157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and nature of circulating immune complexes in melanoma patients.
    Gupta RK; Morton DL
    Contemp Top Immunobiol; 1985; 15():1-53. PubMed ID: 3896641
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic and pathogenetic implications of immune complexes in human cancer.
    Salinas FA; Wee KH
    Adv Immun Cancer Ther; 1986; 2():189-209. PubMed ID: 2962476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
    Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
    Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes in human melanoma: a consequence of deranged immune regulation.
    Jerry LM; Rowden G; Cano PO; Phillips TM; Deutsch GF; Capek A; Hartmann D; Lewis MG
    Scand J Immunol; 1976; 5(6-7):845-59. PubMed ID: 981971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.
    Wong JH; Aguero B; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1988; 27(2):142-6. PubMed ID: 3046746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in cancer patients.
    Jaramillo S; Shafir M; Bekesi G
    Immunol Invest; 1987 Aug; 16(5):383-98. PubMed ID: 3692551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of serial determinations of circulating immune complex levels in malignant melanoma.
    Bukh A; Møller-Larsen A; Aguado MT; Møller-Larsen F; Møller NP
    Cancer Immunol Immunother; 1988; 26(3):280-4. PubMed ID: 3260134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of immune complexes, associated antigen, and antibody in cancer.
    Salinas FA; Wee KH; Silver HK
    Contemp Top Immunobiol; 1985; 15():55-109. PubMed ID: 3896644
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
    Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
    Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in malignant melanoma: serial studies in 130 patients.
    Bharwani N; Campbell L; Ashley P; Queen WD; Phillips TM; Jerry LM
    Oncology; 1986; 43(3):143-8. PubMed ID: 3703459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of a melanoma-specific protein from human urine.
    Bennett C; Cooke KB
    Br J Cancer; 1980 May; 41(5):734-44. PubMed ID: 6158965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.
    Zörnig I; Halama N; Lorenzo Bermejo J; Ziegelmeier C; Dickes E; Migdoll A; Kaiser I; Waterboer T; Pawlita M; Grabe N; Ugurel S; Schadendorf D; Falk C; Eichmüller SB; Jäger D
    Int J Cancer; 2015 Jan; 136(1):138-51. PubMed ID: 24839182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses induced by human malignant melanoma in the rabbit.
    Goodwin DP; Hornung MO; Leong SP; Krementz ET
    Surgery; 1972 Nov; 72(5):737-43. PubMed ID: 4117015
    [No Abstract]   [Full Text] [Related]  

  • 20. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 196.